Annual Total Expenses
$43.61 M
+$6.07 M+16.16%
December 31, 2023
Summary
- As of February 8, 2025, TARA annual total expenses is $43.61 million, with the most recent change of +$6.07 million (+16.16%) on December 31, 2023.
- During the last 3 years, TARA annual total expenses has risen by +$9.17 million (+26.62%).
- TARA annual total expenses is now -8.16% below its all-time high of $47.49 million, reached on December 31, 2021.
Performance
TARA Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$12.33 M
+$1.67 M+15.66%
September 30, 2024
Summary
- As of February 8, 2025, TARA quarterly total expenses is $12.33 million, with the most recent change of +$1.67 million (+15.66%) on September 30, 2024.
- Over the past year, TARA quarterly total expenses has increased by +$1.63 million (+15.23%).
- TARA quarterly total expenses is now -9.20% below its all-time high of $13.58 million, reached on March 31, 2021.
Performance
TARA Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
TARA Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.2% | +15.2% |
| 3 y3 years | +26.6% | +15.2% |
| 5 y5 years | +104.1% | +15.2% |
TARA Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.2% | +16.2% | at high | +54.6% |
| 5 y | 5-year | -8.2% | +457.0% | -9.2% | +389.4% |
| alltime | all time | -8.2% | +457.0% | -9.2% | +763.0% |
Protara Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $12.33 M(+15.7%) |
| Jun 2024 | - | $10.66 M(-10.0%) |
| Mar 2024 | - | $11.85 M(+7.3%) |
| Dec 2023 | $43.61 M(+16.2%) | $11.04 M(+3.2%) |
| Sep 2023 | - | $10.70 M(-11.9%) |
| Jun 2023 | - | $12.14 M(+24.7%) |
| Mar 2023 | - | $9.73 M(-2.6%) |
| Dec 2022 | $37.55 M(-20.9%) | $9.99 M(+25.3%) |
| Sep 2022 | - | $7.97 M(-8.4%) |
| Jun 2022 | - | $8.71 M(-19.9%) |
| Mar 2022 | - | $10.87 M(+5.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $47.49 M(+37.9%) | $10.29 M(-5.0%) |
| Sep 2021 | - | $10.83 M(-15.3%) |
| Jun 2021 | - | $12.79 M(-5.8%) |
| Mar 2021 | - | $13.58 M(+51.6%) |
| Dec 2020 | $34.44 M(+339.9%) | $8.96 M(+11.1%) |
| Sep 2020 | - | $8.06 M(+11.0%) |
| Jun 2020 | - | $7.27 M(-28.5%) |
| Mar 2020 | - | $10.16 M(+303.3%) |
| Dec 2019 | $7.83 M(-63.4%) | $2.52 M(+7.0%) |
| Sep 2019 | - | $2.35 M(+64.8%) |
| Jun 2019 | - | $1.43 M |
| Dec 2018 | $21.37 M | - |
FAQ
- What is Protara Therapeutics annual total expenses?
- What is the all time high annual total expenses for Protara Therapeutics?
- What is Protara Therapeutics annual total expenses year-on-year change?
- What is Protara Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Protara Therapeutics?
- What is Protara Therapeutics quarterly total expenses year-on-year change?
What is Protara Therapeutics annual total expenses?
The current annual total expenses of TARA is $43.61 M
What is the all time high annual total expenses for Protara Therapeutics?
Protara Therapeutics all-time high annual total expenses is $47.49 M
What is Protara Therapeutics annual total expenses year-on-year change?
Over the past year, TARA annual total expenses has changed by +$6.07 M (+16.16%)
What is Protara Therapeutics quarterly total expenses?
The current quarterly total expenses of TARA is $12.33 M
What is the all time high quarterly total expenses for Protara Therapeutics?
Protara Therapeutics all-time high quarterly total expenses is $13.58 M
What is Protara Therapeutics quarterly total expenses year-on-year change?
Over the past year, TARA quarterly total expenses has changed by +$1.63 M (+15.23%)